Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.57 |
| ▸ | HPGD | P15428 | 3/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.57 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.47 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.47 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.44 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.44 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.44 |
| ▸ | BRD4 | O60885 | 1/20 | 0.43 |
| ▸ | ACACB | O00763 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14101266 | 0.88 | HSD11B1 (0.52) | HSD11B1ALDH1A1HPGDSMN1; SMN2EPHX2 | |
| SCHEMBL16242079 | 0.86 | ALDH1A1 (0.55) | HSD11B1ALDH1A1HPGDSMN1; SMN2EPHX2 | |
| SCHEMBL14100861 | 0.86 | HSD11B1 (0.51) | HSD11B1ALDH1A1HPGDSMN1; SMN2EPHX2 | |
| SCHEMBL17758155 | 0.85 | HSD11B1 (0.50) | HSD11B1ALDH1A1HPGDSMN1; SMN2EPHX2 | |
| SCHEMBL7745696 | 0.85 | ALDH1A1 (0.53) | HSD11B1ALDH1A1HPGDSMN1; SMN2EPHX2 | |
| SCHEMBL16242078 | 0.85 | ALDH1A1 (0.53) | HSD11B1ALDH1A1HPGDSMN1; SMN2EPHX2 | |
| SCHEMBL18193472 | 0.85 | ALDH1A1 (0.53) | HSD11B1ALDH1A1HPGDSMN1; SMN2EPHX2 | |
| SCHEMBL21015325 | 0.82 | ALDH1A1 (0.50) | HSD11B1ALDH1A1HPGDSMN1; SMN2EPHX2 | |
| SCHEMBL1004649 | 0.80 | ALDH1A1 (0.73) | ALDH1A1HPGDSMN1; SMN2EPHX2NR1H4 | |
| SCHEMBL505778 | 0.79 | ALDH1A1 (0.55) | HSD11B1ALDH1A1HPGDSMN1; SMN2EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12551570-B2 | Compounds comprising cleavable linker and uses thereof | INTOCELL, INC. (KR) | 2026-02-17 | — | — | US | disclosed |
| US-12479927-B2 | Compounds comprising cleavable linker and uses thereof | INTOCELL, INC. (KR) | 2025-11-25 | — | — | US | disclosed |
| US-20250213712-A1 | ANTIBODY DRUG CONJUGATES COMPRISING CAMPTOTHECIN DERIVATIVES AND USES THEREOF | INTOCELL, INC. (KR) | 2025-07-03 | — | — | US | disclosed |
| US-12274898-B2 | Substituted benzodiazepines as antibody-drug conjugates | INTOCELL, INC. (KR) | 2025-04-15 | — | — | US | disclosed |
| EP-4452328-A1 | ANTIBODY DRUG CONJUGATES COMPRISING TOXINS WITH POLAR GROUPS AND USES THEREOF | Intocell, Inc. (KR) | 2024-10-30 | — | — | EP | disclosed |
| US-20230406877-A1 | COMPOUNDS COMPRISING CLEAVABLE LINKER AND USES THEREOF | INTOCELL, INC. (KR) | 2023-12-21 | — | — | US | disclosed |
| US-11807628-B2 | Benzodiazepine derivatives and uses thereof | INTOCELL, INC. (KR) | 2023-11-07 | — | — | US | disclosed |
| US-11753431-B2 | Compounds comprising cleavable linker and uses thereof | INTOCELL, INC. (KR) | 2023-09-12 | — | — | US | disclosed |
| WO-2023118961-A1 | ANTIBODY DRUG CONJUGATES COMPRISING TOXINS WITH POLAR GROUPS AND USES THEREOF | INTOCELL, INC. (KR) | 2023-06-29 | — | — | WO | disclosed |
| US-20230190939-A1 | ANTIBODY DRUG CONJUGATES COMPRISING TOXINS WITH POLAR GROUPS AND USES THEREOF | INTOCELL, INC. (KR) | 2023-06-22 | — | — | US | disclosed |
| WO-2008061032-A1 | OPTICAL DATA RECORDING AND IMAGING ON MEDIA USING APOCHROMATIC LENSES | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2008-05-22 | — | — | WO | disclosed |
| WO-2008061030-A1 | OPTICAL DATA RECORDING AND IMAGING ON MEDIA USING APOCHROMATIC LENSES AND A LIGHT SEPARATING MEANS | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2008-05-22 | — | — | WO | disclosed |
| US-20080050672-A1 | LIGHT ACTIVATED CONTRAST SYSTEMS USING MASKED DEVELOPERS FOR OPTICAL DATA RECORDING | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. | 2008-02-28 | — | — | US | disclosed |
| WO-2008024984-A1 | LIGHT ACTIVATED CONTRAST SYSTEMS USING MASKED DEVELOPERS FOR OPTICAL DATA RECORDING | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2008-02-28 | — | — | WO | disclosed |
| US-20070265296-A1 | Nuclear receptor binding agents | GTX, INC. | 2007-11-15 | — | — | US | disclosed |
| WO-2007062230-A2 | NUCLEAR RECEPTOR BINDING AGENTS | GTX, INC. (US) | 2007-05-31 | — | — | WO | disclosed |
| US-20050254551-A1 | Temperature monitoring system | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. | 2005-11-17 | — | — | US | disclosed |
| US-6958181-B1 | Protected activators for use in leuco dye compositions | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2005-10-25 | — | — | US | disclosed |
| US-20050227034-A1 | PROTECTED ACTIVATORS FOR USE IN LEUCO DYE COMPOSITIONS | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. | 2005-10-13 | — | — | US | disclosed |
| WO-2005025885-A1 | PROTECTED ACTIVATORS FOR USE IN LEUCO DYE COMPOSITIONS | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2005-03-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230190939-A1 | ANTIBODY DRUG CONJUGATES COMPRISING TOXINS WITH POLAR GROUPS AND USES THEREOF | CD47, ENPP2, CD2 | HSD11B1 3801/4885ALDH1A1 4468/4885HPGD 4281/4885 |
| US-11807628-B2 | Benzodiazepine derivatives and uses thereof | GABRB3, GABRB2, GABRB1 | HSD11B1 735/4885ALDH1A1 900/4885HPGD 471/4885 |
| US-20250213712-A1 | ANTIBODY DRUG CONJUGATES COMPRISING CAMPTOTHECIN DERIVATIVES AND USES THEREOF | CD47, TOP2A, SSB | HSD11B1 3855/4885ALDH1A1 2732/4885HPGD 1599/4885 |
| US-12551570-B2 | Compounds comprising cleavable linker and uses thereof | FCGR2A, FCGR3B, FCGR1A | HSD11B1 4306/4885ALDH1A1 4586/4885HPGD 4856/4885 |
| US-20070265296-A1 | Nuclear receptor binding agents | GPER1, ESRRG, ESR2 | HSD11B1 272/4885ALDH1A1 3644/4885HPGD 1070/4885 |
| US-20230406877-A1 | COMPOUNDS COMPRISING CLEAVABLE LINKER AND USES THEREOF | VIP, ANTXR2, TNFRSF9 | HSD11B1 4588/4885ALDH1A1 4822/4885HPGD 2968/4885 |
| US-12479927-B2 | Compounds comprising cleavable linker and uses thereof | VIP, ANTXR2, TNFRSF9 | HSD11B1 4588/4885ALDH1A1 4822/4885HPGD 2968/4885 |
| US-11753431-B2 | Compounds comprising cleavable linker and uses thereof | VIP, ANTXR2, TNFRSF9 | HSD11B1 4588/4885ALDH1A1 4822/4885HPGD 2968/4885 |
| US-12274898-B2 | Substituted benzodiazepines as antibody-drug conjugates | GABRA3, GABRA6, GABRA4 | HSD11B1 668/4885ALDH1A1 207/4885HPGD 2221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.